AN experience with 335 cases of carcinoma of the esophagus forms the background ... Because of these tragically low survival figures we were happy to add supervoltage radiation to our armamentarium.

“The current trial showed that overall survival was better with FLOT than with preoperative chemoradiotherapy among patients with resectable esophageal adenocarcinoma, including those with a ...

According to the National Cancer Institute, the five-year relative survival rate after ... the UK has one of the highest rates globally of esophageal adenocarcinoma, a subtype of this disease ...

For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with FLOT leads to improved survival compared with preoperative chemoradiotherapy.

"Our study used a methodically rigorous process to identify biomarkers, and we believe this represents the first study to select biomarkers for Barrett's esophagus, esophageal adenocarcinoma and ...

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...

6 In the ESOPEC trial, we assessed whether FLOT was superior to preoperative chemoradiotherapy regarding overall survival among patients with resectable esophageal adenocarcinoma. The ESOPEC trial ...

Overall survival at 3 years was 57.4% and 50. ... a phase 3 multicenter trial involving patients with resectable esophageal adenocarcinoma who were randomly assigned to receive perioperative ...